怀孕期间通过管理策略和考虑来导航原发性免疫性血小板缩:全面的审查
S M Dahiphale1, Deepika Dewani1, Manjusha Agrawal1
1Obstetrics and Gynaecology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus
|September 24, 2024
概括
怀孕期间的原发性免疫性血栓缩症 (ITP) 需要谨慎管理,以预防孕产妇出血和新生儿血栓缩症. 本综述详细介绍了ITP病理生理学,诊断和治疗选择,以获得最佳的孕产妇和胎儿结果.
科学领域:
- 产科和妇科 产科和妇科
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 初级免疫性血小板缺血 (ITP) 是一种自身免疫性疾病,导致血小板数量低.
- 怀孕期间的ITP对母亲和胎儿都有风险,包括出血和新生儿血栓塞缩症.
- 个性化护理对于在怀孕期间管理ITP至关重要.
研究的目的:
- 为孕妇提供ITP病理生理学,诊断和管理的全面审查.
- 强调多学科的护理和个性化的治疗策略.
- 加强临床决策,以改善ITP怀孕中母亲和胎儿的结果.
主要方法:
- 对当前实践和新兴治疗方法的文献综述 怀孕期间的ITP.
- 对诊断标准和管理准则的分析.
- 综合关于一线和二线治疗选择的信息.
主要成果:
- 怀孕期间ITP的发病率很大,有可能导致严重的并发症.
- 皮质类固醇和IVIG是常见的第一线治疗方法.
- 免疫抑制剂和TPO-RA被认为是二线选择.
结论:
- 在怀孕期间有效管理ITP需要多学科的合作.
- 治疗计划需要仔细监测并根据血小板缺血的严重程度和妊娠阶段进行调整.
- 本次审查旨在通过对当前和新兴ITP疗法的详细分析来改善结果.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
496
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
496
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
649
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
649